Dextran high molecular weight and Panitumumab Intravenous
Determining the interaction of Dextran high molecular weight and Panitumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dextran, high molecular weight
Brand name: Dextran 70 6% in 5% Dextrose, Hyskon, Macrodex, Gentran 70, Dextran-HM, Dextran 70 6% in 09% Sodium Chloride
Synonyms: Dextran (high molecular weight), Dextran 75
Generic Name: panitumumab
Brand name: Vectibix
Synonyms: Panitumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextran high molecular weight-Panixine
- Dextran high molecular weight-Panixine DisperDose
- Dextran high molecular weight-Panlor
- Dextran high molecular weight-Panlor Tablet
- Dextran high molecular weight-Panlor Tablets
- Dextran high molecular weight-Panlor-DC
- Panitumumab Intravenous-Dextranomer and Hyaluronate Derivatives (Deflux)
- Panitumumab Intravenous-Dextranomer and Hyaluronate Derivatives (Solesta)
- Panitumumab Intravenous-Dextranomer and sodium hyaluronate
- Panitumumab Intravenous-Dextroamphetamine
- Panitumumab Intravenous-Dextroamphetamine and amphetamine
- Panitumumab Intravenous-Dextroamphetamine and Amphetamine Extended-Release Capsules (Adderall XR)